The increased protein secretion associated with tumor development and invasiveness has made S100A4 a good biomarker for different metastatic cancers, where it also assumes a prognostic value, since its increase is associated with poor patients survival [12,13,14,15,16]. The gene discussed is S100A4; the disease is metastatic malignant neoplasm.